Triple monoclonal protein-related kidney lesions in a patient with plasma cell dyscrasia: a case report

Arsalan Alvi1, Alexander J Gallan2, Nattawat Klomjit1

  • 1Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

Frontiers in Nephrology
|November 25, 2024
PubMed

Insights

This study reports a rare case of monoclonal gammopathy of renal significance (MGRS) presenting with three distinct kidney lesions, emphasizing the nephrotoxic potential of monoclonal proteins.

Area of Science:

  • Nephrology
  • Hematology
  • Oncology

Background:

  • Monoclonal proteins typically cause single kidney pathologies.
  • Multiple lesions are rare and indicate a poor prognosis.

Observation:

  • A 57-year-old male developed glomerulonephritis post-diverticulitis.
  • Kidney biopsy revealed light chain cast nephropathy, proximal tubulopathy, and thrombotic microangiopathy.
  • Minimal hematological burden (IgG kappa M-spike 0.2 g/dl, 3% plasma cells) was noted.

Findings:

  • The patient had monoclonal gammopathy of renal significance (MGRS) with a highly toxic light chain.
  • Despite clone-directed therapy and complement blockade, the patient remained dialysis-dependent.
  • This is the first reported MGRS case with three distinct kidney lesions.

Implications:

  • Highlights the critical role of monoclonal protein toxicity in kidney disease.
  • Suggests aggressive therapy may be needed to eradicate clones for organ response.
  • Underscores the rarity of triple monoclonal protein-related kidney lesions outside multiple myeloma.